Advertisement

Topics

FDA Clears Long-Acting ADHD Drug Mydayis

07:44 EDT 21 Jun 2017 | Medscape

Mydayis (mixed salts of amphetamine) is formulated to last up to 16 hours and is approved for adults and children aged 13 years and older.
News Alerts

Original Article: FDA Clears Long-Acting ADHD Drug Mydayis

NEXT ARTICLE

More From BioPortfolio on "FDA Clears Long-Acting ADHD Drug Mydayis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...